Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Parasites & Vectors|May 6, 2018
Targeting cattle for malaria elimination: marked reduction of Anopheles arabiensis survival for over six months using a slow-release ivermectin implant formulationCarlos J Chaccour, Kija Ngha'bi, Gloria Abizanda, et al.
Microbiology Spectrum|May 11, 2023
A Reagent and Virus Benchmarking Panel for a Uniform Analytical Performance Assessment of N Antigen-Based Diagnostic Tests for COVID-19Allison Golden, Jason L Cantera, Lorraine Lillis, et al.
Malaria Journal|December 1, 2023
Assessing national vector control micro-planning in Zambia using the 2021 malaria indicator surveyIrene Kyomuhangi, Andrew Andrada, Zhiyuan Mao, et al.
Malaria Journal|June 13, 2015
Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agendaCarlos J Chaccour, N Regina Rabinovich, Hannah Slater, et al.
Malaria Journal|August 29, 2019
Field performance of the malaria highly sensitive rapid diagnostic test in a setting of varying malaria transmissionJulia Mwesigwa, Hannah Slater, John Bradley, et al.
Malaria Journal|March 17, 2023
Effectiveness of community case management of malaria on severe malaria and inpatient malaria deaths in Zambia: a dose-response study using routine health information system dataRuth A Ashton, Busiku Hamainza, Chris Lungu, et al.
Malaria Journal|April 4, 2025
Estimating malaria antigen dynamics and the time to negativity of next-generation malaria rapid diagnostic testsWilliam Sheahan, Allison Golden, Rebecca Barney, et al.
The Lancet. Infectious Diseases|December 17, 2021
Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The GambiaEdgard D Dabira, Harouna M Soumare, Bakary Conteh, et al.
BMJ Open|July 7, 2023
Protocol for a cluster randomised placebo-controlled trial of adjunctive ivermectin mass drug administration for malaria control on the Bijagós Archipelago of Guinea-Bissau: the MATAMAL trialHarry Hutchins, John Bradley, Elizabeth Pretorius, et al.
Medrxiv : the Preprint Server for Health Sciences|October 31, 2023
Global risk of selection and spread of Plasmodium falciparum histidine-rich protein 2 and 3 gene deletionsOliver J Watson, Thu Nguyen-Anh Tran, Robert J Zupko, et al.
Pageof 3